Search

Bing Living Li

from Redwood City, CA
Age ~65
Get Report
Also known as:
Li Bing
Related to:
Karen W Stone, 50
Connected to:
Ai Q Li, 64Ai H Li, 81Aida Li, 67Aijun Li, 65Aiwen Q Li, 56Aiyan Li, 61Alan Li, 80Alice Li, 46Alida Li, 59Alisha Li, 31

Bing Li Phones & Addresses

  • Redwood City, CA
  • Fremont, CA
  • San Francisco, CA
  • Saratoga, CA
  • Vernon Rockville, CT
  • Oakland, CA

Professional Records

Medicine Doctors

Bing Li Photo 1

Bing Li

View page
Specialties:
Anesthesiology
Education:
Beijing School Of Medicine (1989)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Bing Q. Li
Principal
B&Q Construction Co
Single-Family House Construction
808 31 Ave, San Francisco, CA 94121
Bing Li
Rbl Investment Enterprise LLC
316 Dolphin Isle, San Mateo, CA 94404
Bing Hong Li
Friends of Real Estate Investment LLC
2980 Privet Dr, Burlingame, CA 94010
Bing Zhen Li
Managing
Marina Childcare LLC
Child Day Care Service
15122 Flying Mist Rd, San Leandro, CA 94579

Publications

Us Patents

Vascular Endothelial Cell Growth Factor Variants And Uses Thereof

View page
US Patent:
7090834, Aug 15, 2006
Filed:
Apr 10, 2000
Appl. No.:
09/546857
Inventors:
Brian C. Cunningham - San Mateo CA, US
Abraham M. de Vos - Oakland CA, US
Bing Li - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12N 15/16
A61K 38/18
C07H 21/04
US Classification:
424 851, 435 71, 435 72, 435 691, 435 694, 435325, 4352523, 43525411, 4353201, 530399, 436501, 536 235, 536 2351, 930120
Abstract:
The present invention provides VEGF variants having one or more amino acid mutations in the KDR and/or FLT-1 receptor binding domains in the native VEGF sequence and selective binding affinity for either the KDR receptor or the FLT-1 receptor. Methods of making the VEGF variants and methods of using the VEGF variants are also provided.

Data Analysis Flow Engine

View page
US Patent:
7093207, Aug 15, 2006
Filed:
Nov 17, 2003
Appl. No.:
10/715082
Inventors:
Po-Shou Liao - Keelung, TW
Benny Huang - Jhonghe, TW
Charles Lai - Taipei, TW
Jimmy Liao - Erlin Township, TW
Bing Li - Fremont CA, US
Peter Eldredge - Scotts Valley CA, US
Leslie F. Smith - Puyallup WA, US
Felix Lai - Jhongjheng District, TW
Sino Ho - Hsinchu, TW
Ellis E-Li Chang - Saratoga CA, US
Sandeep Bhagwat - Milpitas CA, US
Anthony Cheung - Milpitas CA, US
Michael J. Bellon - Gilroy CA, US
Assignee:
KLA-Tencor Technologies Corporation - Milpitas CA
International Classification:
G06F 17/50
G06F 12/00
G06F 19/00
US Classification:
716 1, 707203, 700121
Abstract:
An extensible data analysis system for analyzing integrated circuit fabrication data produced during integrated circuit fabrication, including an application tier that selectively runs analysis nodes. The application tier has an architecture for optionally including and excluding a desired selection of the analysis nodes. The application tier architecture allows the selection of the analysis nodes to be dynamically added by a user. A data access tier selectively runs data reader nodes. The data access tier has an architecture for optionally including and excluding a desired selection of the data reader nodes. The data reader nodes interpret a desired variety of data source files containing the integrated circuit fabrication data having different formats for access by the application tier. The data access tier architecture allows the selection of the data reader nodes to be dynamically added by the user.

Vascular Endothelial Cell Growth Factor Variants And Uses Thereof

View page
US Patent:
20060063203, Mar 23, 2006
Filed:
Aug 16, 2005
Appl. No.:
11/204554
Inventors:
Brian Cunningham - San Mateo CA, US
Abraham de Vos - Oakland CA, US
Bing Li - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
G01N 33/53
C07H 21/04
C12P 21/06
C07K 14/475
A61K 38/18
US Classification:
435007100, 514012000, 530399000, 536023500, 435069100, 435320100, 435325000
Abstract:
The present invention provides VEGF variants having at least a single amino acid mutation in the native VEGF sequence and selective binding affinity for either the KDR receptor or the FLT-1 receptor. Methods of making the VEGF variants and methods of using the VEGF variants are also provided.

Vascular Endothelial Cell Growth Factor Variants And Uses Thereof

View page
US Patent:
20060269997, Nov 30, 2006
Filed:
Mar 15, 2006
Appl. No.:
11/376990
Inventors:
Brian Cunningham - San Mateo CA, US
Abraham de Vos - Oakland CA, US
Bing Li - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 14/475
C07H 21/04
C12P 21/06
US Classification:
435069100, 435320100, 435325000, 530399000, 536023500
Abstract:
The present invention provides VEGF variants having at least a single amino acid mutation in the native VEGF sequence and selective binding affinity for either the KDR receptor or the FLT-1 receptor. Methods of making the VEGF variants and methods of using the VEGF variants are also provided.

Apo2L(Trail) Receptor Binding Peptides And Uses Thereof

View page
US Patent:
20070066800, Mar 22, 2007
Filed:
Apr 29, 2004
Appl. No.:
10/556106
Inventors:
Sachdev Sidhu - San Francisco CA, US
Bing Li - Foster City CA, US
International Classification:
C07K 14/74
C07K 16/28
C07H 21/04
C12P 21/06
US Classification:
530350000, 536023500, 530388220, 435069100, 435358000, 435252330, 435254200
Abstract:
Peptides are provided that bind Apo-2L receptor molecules. These peptides can be used for example in methods where a modulation of the biological activities of Apo-2L and/or Apo-2L receptor molecules such as DR5 is desired.

Vascular Endothelial Cell Growth Factor Variants And Uses Thereof

View page
US Patent:
20070142284, Jun 21, 2007
Filed:
Sep 29, 2006
Appl. No.:
11/536897
Inventors:
Brian Cunningham - San Mateo CA, US
Abraham de Vos - Oakland CA, US
Bing Li - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 38/18
C07K 14/475
C07H 21/04
C12P 21/06
US Classification:
514012000, 530399000, 435069100, 435320100, 435325000, 536023500
Abstract:
The present invention provides VEGF variants having at least a single amino acid mutation in the native VEGF sequence and selective binding affinity for either the KDR receptor or the FLT-1 receptor. Methods of making the VEGF variants and methods of using the VEGF variants are also provided.

Dr5 Antibodies And Uses Thereof

View page
US Patent:
20080248037, Oct 9, 2008
Filed:
Apr 4, 2005
Appl. No.:
11/547457
Inventors:
Bing Li - Foster City CA, US
Sachdev S. Sidhu - San Francisco CA, US
Assignee:
Genentech, Inc. - San Francisco CA
International Classification:
A61K 39/395
C07K 16/18
A61P 43/00
US Classification:
4241381, 5303871, 5303873, 4241721
Abstract:
The application provides antibodies which specifically bind to DR5 receptor. The anti-DR5 antibodies optionally contain CDR sequences identified using phage-display techniques. The DR5 antibodies can be used, for example, in methods where a modulation of the biological activities of Apo-2L and/or Apo-2L receptors is desired, including cancer and immune-related conditions.

Affinity Matured Crig Variants

View page
US Patent:
20100150908, Jun 17, 2010
Filed:
May 6, 2009
Appl. No.:
12/387794
Inventors:
Sachdev S. Sidhu - Toronto, CA
Bing Li - Foster City CA, US
Menno Van Lookeren Campagne - San Francisco CA, US
Christian Wiesmann - Brisbane CA, US
International Classification:
A61K 39/395
C12P 21/08
A61P 27/02
A61P 19/02
US Classification:
4241331, 5303873
Abstract:
The present invention concerns affinity matured CRIg variants. In particular, the invention concerns CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3.

Isbn (Books And Publications)

Yin Hang Jian Guan Bian Jie Wen Ti Yan Jiu

View page
Author

Bing Li

ISBN #

7504937614

Hai Jun Ying Hao: Ren Min Hai Jun Ying Mo Hui Cui

View page
Author

Bing Li

ISBN #

7801517741

Control profile
Bing Living Li from Redwood City, CA, age ~65 Get Report